1Youcef MR, Reiner PR. 1-β-arabinofuranosylcytosine in therapy of leukemia: Preclinical and clinical overview.Pharmacol Ther, 1992, 56 : 307- 321.
2Alena WE, Jean MS, Peter A, et al. Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML. Leuk Res, 1998, 22 : 373 - 378.
3Pourquier P,Takebayashi Y, Urasaki Y, et al. Induction of topoisomerase I cleavage complexes by 1-β-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells. Proc Natl Acad USA, 2000, 97 : 1885 - 1890.
4Leardi A, Caraglia M, Selleri C, et al. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. Br J Haematol, 1998, 102 : 746- 752.
5Funato T, Satou J, Nishiyama Y, et al. In vitro leukemia cell models of ara-C resistance. Leuk Res, 2000, 24 : 535- 541.
6Lengfelder E, Reichert A, Schoch C, et al. Double induction strategy including high dose cytarabine in combination with all- trans retinoic acid: Effects in patients with newly diagnosed acute promyelocytic leukemia. Leukemia, 2000, 14 :1362- 1370.
7Buchner T, Hiddemann W, Wormann B, et al. Double induction strategy for acute myeloid leukemia: The effect of high-dose cytaraine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: A randomized trial by the German AML Cooperative Group. Blood, 1999, 93 :4116- 4124.
8Seymour JF, Juneja SK, Campbell LJ, et al, Secondary acute myeloid leukemia with inv(16): Report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia, 1999, 13 : 1735- 1740.
9Lech- Maranda E, Korycka A, Robak T: Patients with t(8; 21)(q22; q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. Haematologica, 2000, 85 : 588-594.
10Ghaddar HM, Plunkett W, Kantarjian HM, et al. Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside. Leukemia, 1994,8 : 1269- 1274.
6Hong K N,Na Y P,Shin H L,et al.Antibacterial activity of chitosans and chitosan oligomers with different molecular weights[J].International Journal of Food Microbiology,2002,74(1):65-72.
7Zhai M,Zhao L,Yoshii F,et al.Study on antibacterial starch/chitosan blend film formed under the action of irradiation[J].Carbohydrate Polymers,2004,57(1):83-88.
8Wang S B,Chen A Z,Weng L J.Effect of Drug-loading methods on drug load,encapsulation efficiency and release properties of alginate/poly-L-arginine/ chitosan ternary complex microcapsules[J].Macromol.Biosci.,2004,4(1):27-30.
